FIRST-IN-CLASS NAE INHIBITOR MLN4924 IN COMBINATION WITH AZACITIDINE FOR ACUTE MYELOID LEUKEMIA (AML) PATIENTS CONSIDERED UNFIT FOR CONVENTIONAL CHEMOTHERAPY: RESULTS FROM THE C15009 TRIAL

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Swords, RT; Savona, MR; Maris, MB; Erba, HP; Hua, Z; Faessel, H; Blakemore, SJ; Sedarati, F; Dezube, BJ; Medeiros, BC

Published Date

  • June 1, 2014

Published In

Volume / Issue

  • 99 /

Start / End Page

  • 223 - 224

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0390-6078

Conference Name

  • 19th Congress of the European-Hematology-Association

Conference Location

  • Milan, ITALY

Conference Start Date

  • June 12, 2014

Conference End Date

  • June 15, 2014